Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 7.07 CAD 13.3%
Market Cap: 2.6B CAD

Intrinsic Value

The intrinsic value of one BHC stock under the Base Case scenario is 92.6 CAD. Compared to the current market price of 7.07 CAD, Bausch Health Companies Inc is Undervalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BHC Intrinsic Value
92.6 CAD
Undervaluation 92%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

Bausch Health Companies Inc
TSX:BHC
CA
Pharmaceuticals
Market Cap
2.6B CAD
IPO
Sep 20, 1994
CA
Pharmaceuticals
Market Cap
2.6B CAD
IPO
Sep 20, 1994
Price
CA$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BHC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bausch Health Companies Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bausch Health Companies Inc

Current Assets 5.8B
Cash & Short-Term Investments 1.2B
Receivables 2.1B
Other Current Assets 2.5B
Non-Current Assets 20.7B
PP&E 1.8B
Intangibles 16.6B
Other Non-Current Assets 2.3B
Efficiency

Free Cash Flow Analysis
Bausch Health Companies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bausch Health Companies Inc

Revenue
9.6B USD
Cost of Revenue
-2.8B USD
Gross Profit
6.8B USD
Operating Expenses
-5B USD
Operating Income
1.9B USD
Other Expenses
-1.9B USD
Net Income
-46m USD
Fundamental Scores

BHC Profitability Score
Profitability Due Diligence

Bausch Health Companies Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Free Cash Flow
Positive 3-Years Revenue Growth
49/100
Profitability
Score

Bausch Health Companies Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

BHC Solvency Score
Solvency Due Diligence

Bausch Health Companies Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
28/100
Solvency
Score

Bausch Health Companies Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BHC Price Targets Summary
Bausch Health Companies Inc

Wall Street analysts forecast BHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BHC is 9.44 CAD with a low forecast of 9.09 CAD and a high forecast of 9.98 CAD.

Lowest
Price Target
9.09 CAD
29% Upside
Average
Price Target
9.44 CAD
33% Upside
Highest
Price Target
9.98 CAD
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BHC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

BHC News

Other Videos